Overview

An Observational Study to Examine the Patients With Isolated Systolic Hypertonia (ISH) Under Therapy With EneasĀ® (NIS ENEAS ISH)

Status:
Completed
Trial end date:
2009-08-01
Target enrollment:
Participant gender:
Summary
This non interventional, multicentric, uncontrolled, prospective, observational study was planned to observe the course of disease in subjects with ISH, who were treated with Eneas.
Details
Lead Sponsor:
Merck KGaA
Merck KGaA, Darmstadt, Germany
Treatments:
Enalapril
Enalaprilat
Nitrendipine